サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1363279

ソフトジェルカプセルの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

Softgel Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin-based/Animal-based, Non-animal-based), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 136 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
ソフトジェルカプセルの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月26日
発行: Grand View Research
ページ情報: 英文 136 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ソフトジェルカプセル市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のソフトジェルカプセル市場規模は、2023年から2030年にかけて6.9%のCAGRを記録し、2030年までに130億9,000万米ドルに達すると推定されています。

ソフトジェルカプセルは、難溶性薬物の製剤として選択され、ほとんどの薬物分子の吸収時間を高めることが証明されています。錠剤や他の経口製剤よりも優れているため、世界中でソフトジェルカプセルの採用が増加しています。飲み込みやすさ、味のマスキング、生物学的利用能の向上、非反応性、審美的魅力、保存期間の延長などが、広く受け入れられる要因となっています。

Catalent社、Eurocaps社などの大手企業は、ビーガン用カプセルを開発し、ビーガン消費者の裾野を広げようとしています。ファイザー、ノバルティス、バイエル、プロクター・アンド・ギャンブルなどの大手製薬会社は、競争の激しい市場でコスト効率の高い製品を提供するため、大手受託製造機関（CMO）と提携しています。SaRS-CoV-2ウイルスによる呼吸器感染症を治療する経口ワクチンを開発する研究が、ソフトジェルメーカーの研究開発に拍車をかけています。さらに、より健康的なライフスタイルや免疫力を高めるビタミンへのシフトも、COVID-19パンデミックの発生後にソフトカプセル市場を急増させています。

ソフトジェルカプセル市場レポートハイライト

  • ゼラチンベース／動物由来セグメントが2022年に最大の収益シェアを占めました。
  • 栄養補助食品企業セグメントが2022年に37.7%の最大収益シェアで市場を独占し、予測期間中に8.2%の最速CAGRで拡大する見込み。
  • 北米は2022年に42.3％の最大収益シェアで市場を独占したが、これは生産技術の向上、同地域内の主要プレイヤーの存在、製品ポートフォリオを拡大するための研究開発への支出の増加によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ソフトジェルカプセル市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • ソフトジェルカプセル市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ソフトジェルカプセル：タイプ別推定・動向分析

  • ソフトジェルカプセル市場： タイプの重要なポイント
  • ソフトジェルカプセル市場：タイプの動きと市場シェア分析、2022年と2030年
  • ゼラチン系/動物系
  • 非動物ベース

第5章 ソフトジェルカプセル：用途別推定・動向分析

  • ソフトジェルカプセル市場：用途の重要なポイント
  • ソフトジェルカプセル市場：用途の動きと市場シェア分析、2022年と2030年
  • 制酸剤および整腸剤の製剤
  • 抗貧血剤
  • 抗炎症薬
  • 抗生物質および抗菌薬
  • 咳止めと風邪薬
  • 健康補助食品
  • ビタミンと栄養補助食品
  • 妊娠

第6章 ソフトジェルカプセル：最終用途別推定・動向分析

  • ソフトジェルカプセル市場： 最終用途における重要なポイント
  • ソフトジェルカプセル市場：最終用途の動向と市場シェア分析、2022年と2030年
  • 製薬会社
  • ニュートラシューティカル企業
  • 化粧品会社
  • 受託製造組織

第7章 ソフトジェルカプセル市場：地域別推定・動向分析

  • 地域別の見通し
  • 地域別ソフトジェルカプセル市場：重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Fuji Capsule
    • Sirio Pharma Co., Ltd.
    • CAPTEK Softgel International Inc.
    • Thermo Fisher Scientific Inc.
    • EyePoint Pharmaceuticals, Inc.
    • Catalent, Inc.
    • EuroCaps
    • Aenova Group
    • Lonza Capsules & Health Ingredients
    • ProCaps Laboratories, LLC
    • Soft Gel Technologies, Inc.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America softgel capsules market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe softgel capsules market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 23 France softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 24 France softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Sweden softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 32 Sweden softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Norway softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 35 Norway softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Denmark softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 38 Denmark softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific softgel capsules market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 48 China softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 49 China softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 51 India softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 52 India softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America softgel capsules market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa softgel capsules market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE softgel capsules market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait softgel capsules market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait softgel capsules market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait softgel capsules market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Softgel capsules: Market outlook
  • Fig. 8 Softgel capsules: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Softgel capsules market driver impact
  • Fig. 14 Softgel capsules market restraint impact
  • Fig. 15 Softgel capsules market strategic initiatives analysis
  • Fig. 16 Softgel capsules market: Type movement analysis
  • Fig. 17 Softgel capsules market: Type outlook and key takeaways
  • Fig. 18 Gelatin-based/Animal-based market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Non-animal-based market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Softgel capsules market: Application movement analysis
  • Fig. 21 Softgel capsules market: Application outlook and key takeaways
  • Fig. 22 Antacid and anti-flatulent preparation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Anti-anemic preparations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Anti-inflammatory drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Antibiotic and antibacterial drugs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Cough and cold preparations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Health supplement market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Vitamin and dietary supplement market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Pregnancy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Softgel capsules market: End use movement analysis
  • Fig. 31 Softgel capsules market: End use outlook and key takeaways
  • Fig. 32 Pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Nutraceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Cosmeceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Contract manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Global softgel capsules market: Regional movement analysis
  • Fig. 37 Global softgel capsules market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million) 
目次
Product Code: GVR-4-68039-637-3

Softgel Capsules Market Growth & Trends:

The global softgel capsules market size is estimated to reach USD 13.09 billion by 2030 registering a CAGR of 6.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Softgel capsules are proven to be the choice of formulation for poorly soluble drugs and enhance the absorption time of most drug molecules. Its advantages over tablets and other oral formulations have led to the increased adoption of softgel capsules across the globe. Ease of swallowing, taste masking, improved bioavailability, non-reactive, aesthetically appealing, and longer shelf life are the factors influencing its wide acceptance.

Leading players like Catalent, Eurocaps, and many others, are developing vegan capsules to broaden their vegan consumer base as the softgel capsule segment registers nearly 40% of their overall revenue. Large Pharma companies like Pfizer, Novartis, Bayer, and Procter and Gamble, collaborate with leading Contract Manufacturing Organizations (CMO) to provide cost-effective products in the highly competitive market. Research to develop an oral vaccine to treat respiratory infection caused by the SaRS-CoV-2 virus has fueled the R&D of softgel manufacturers. Additionally, the shift towards a healthier lifestyle and immunity-boosting vitamins, have also surged the softgel market post the outbreak of the COVID-19 pandemic. 

Softgel Capsules Market Report Highlights:

  • The gelatin-based/ animal-based segment dominated the market with the largest revenue share in 2022.
  • Nutraceutical companies segment dominated the market with the largest revenue share of 37.7% in 2022 and is also expected to expand at the fastest CAGR of 8.2% over the forecast period.
  • North America dominated the market with the largest revenue share of 42.3% in 2022, owing to improved production technology, the presence of major players within the region, and increased expenditure on R&D to widen their product portfolio.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Softgel Capsules Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Softgel Capsules Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Softgel Capsules: Type Estimates & Trend Analysis

  • 4.1. Softgel Capsules Market: Type Key Takeaways
  • 4.2. Softgel Capsules Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Gelatin-Based/Animal-Based
    • 4.3.1. Gelatin-based/Animal-based market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.4. Non-Animal-Based
    • 4.4.1. Non-Animal-Based market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 5. Softgel Capsules: Application Estimates & Trend Analysis

  • 5.1. Softgel Capsules Market: ApplicationKey Takeaways
  • 5.2. Softgel Capsules Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Antacid and Anti-Flatulent Preparation
    • 5.3.1. Antacid and anti-flatulent preparation market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.4. Anti-Anemic Preparations
    • 5.4.1. Anti-anemic preparations market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.5. Anti-Inflammatory Drugs
    • 5.5.1. Anti-inflammatory drugs market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.6. Antibiotic and Antibacterial Drugs
    • 5.6.1. Antibiotic and antibacterial drugs market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.7. Cough and Cold Preparations
    • 5.7.1. Cough and cold preparations market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.8. Health Supplement
    • 5.8.1. Health supplement market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.9. Vitamin and Dietary Supplement
    • 5.9.1. Vitamin and dietary supplement market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.10. Pregnancy
    • 5.10.1. Pregnancy market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 6. Softgel Capsules: End Use Estimates & Trend Analysis

  • 6.1. Softgel Capsules Market: End-use Key Takeaways
  • 6.2. Softgel Capsules Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Pharmaceutical Companies
    • 6.3.1. Pharmaceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
  • 6.4. Nutraceutical Companies
    • 6.4.1. Nutraceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
  • 6.5. Cosmeceutical Companies
    • 6.5.1. Cosmeceutical companies market estimates and forecasts, 2018 to 2030, (USD Million)
  • 6.6. Contract Manufacturing Organizations
    • 6.6.1. Contract manufacturing organizations market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 7. Softgel Capsules Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Softgel Capsules Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Fuji Capsule
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Sirio Pharma Co., Ltd.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. CAPTEK Softgel International Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Thermo Fisher Scientific Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. EyePoint Pharmaceuticals, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Catalent, Inc.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. EuroCaps
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Aenova Group
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Lonza Capsules & Health Ingredients
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. ProCaps Laboratories, LLC
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Soft Gel Technologies, Inc.
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives